Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes

NCT06550063 is registered in ClinicalTrials.gov with St. James's Hospital, Ireland as lead sponsor.

NCT NCT06550063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06550063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes
Lead sponsor
St. James's Hospital, Ireland
Phase
Observational
Overall status
Recruiting
Start date
August 20, 2024
Completion date
August 31, 2025
Enrollment
2,188 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophagus cancer, gastric cancer, her2-low cancer, her2-positive cancer